List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 76 studies with search of: Open Studies | "Mouth Neoplasms"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Oral Cancer Adjuvant Therapy (OCAT) Trial
Condition: Mouth Neoplasms
Intervention: Procedure: Post-operative chemoradiotherapy / accelerated radiotherapy
2 Recruiting Erlotinib Prevention of Oral Cancer (EPOC)
Condition: Oral Cancer
Interventions: Drug: Erlotinib;   Drug: Placebo
3 Recruiting Excision Limits of Oral Cavity Tumor by Narrow Band Imaging
Condition: Oral Cavity Tumor
Interventions: Device: Location of the suspected lesions;   Procedure: Biopsy;   Procedure: Lesion excision/Surgery
4 Unknown † Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
Condition: Oral Cancer
Intervention:
5 Recruiting Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment
Condition: Oral Cavity Cancer
Intervention: Drug: PF-00299804/Placebo
6 Recruiting Pioglitazone for Oral Premalignant Lesions
Conditions: Malignant Neoplasm Overlapping Lip Site;   Mouth Neoplasms;   Malignant Neoplasm of Other and Ill-defined Sites in the Lip, Oral Cavity and Pharynx;   Leukoplakia;   Other Lesions of Oral Mucosa;   Pigmented Oral Mucosal Lesion;   Unspecified Lesions of Oral Mucosa;   Oral Lichenoid Lesions;   Premalignant Lesion;   Other and Unspecified Lesions of Oral Mucosa;   Granuloma and Granuloma-like Lesions of Oral Mucosa;   Diseases of the Oral Soft Tissue, Excluding Lesions Specific for Gingiva and Tongue;   Oral Premalignant Lesion;   Oral Premalignant Neoplasms;   Oral Leukoplakia
Interventions: Drug: Pioglitazone;   Drug: Placebo
7 Recruiting TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer
Conditions: Oropharynx Cancer;   Cavity of the Mouth Cancer
Intervention: Drug: Taxotere, Cisplatin, 5-FU
8 Recruiting Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Salivary Gland Squamous Cell Carcinoma;   Stage 0 Hypopharyngeal Cancer;   Stage 0 Laryngeal Cancer;   Stage 0 Lip and Oral Cavity Cancer;   Stage 0 Nasopharyngeal Cancer;   Stage 0 Oropharyngeal Cancer;   Stage 0 Paranasal Sinus and Nasal Cavity Cancer;   Stage I Salivary Gland Cancer;   Stage I Squamous Cell Carcinoma of the Hypopharynx;   Stage I Squamous Cell Carcinoma of the Larynx;   Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage I Squamous Cell Carcinoma of the Nasopharynx;   Stage I Squamous Cell Carcinoma of the Oropharynx;   Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage I Verrucous Carcinoma of the Larynx;   Stage I Verrucous Carcinoma of the Oral Cavity;   Stage II Salivary Gland Cancer;   Stage II Squamous Cell Carcinoma of the Hypopharynx;   Stage II Squamous Cell Carcinoma of the Larynx;   Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage II Squamous Cell Carcinoma of the Oropharynx;   Stage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage II Verrucous Carcinoma of the Larynx;   Stage II Verrucous Carcinoma of the Oral Cavity;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IVA Salivary Gland Cancer;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Salivary Gland Cancer;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Salivary Gland Cancer;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
Interventions: Other: placebo;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Drug: chemoprevention
9 Recruiting Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Conditions: Mouth Neoplasms;   Head and Neck Neoplasms;   Tongue Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: Rapamycin;   Procedure: Biopsy;   Procedure: Dynamic CT Perfusion;   Procedure: Positron Emission Tomography;   Procedure: Measurement Serum Cytokines
10 Recruiting Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL
Conditions: Oral Cancer;   High-grade Precancer
Intervention: Procedure: Fluorescence visualization device
11 Recruiting Oral Margin Spectroscopy Detection Using Optical Spectroscopy
Condition: Oral Tumors
Interventions: Device: FastEEM4 System;   Device: Multispectral Digital Microscope
12 Recruiting Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers
Conditions: Carcinoma, Squamous Cell;   Mouth Neoplasms;   Oropharyngeal Neoplasms;   Laryngeal Neoplasms;   Hypopharyngeal Neoplasms
Intervention:
13 Recruiting Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Neoplasms;   Laryngeal Neoplasms;   Mouth Neoplasms;   Pharyngeal Neoplasms
Interventions: Drug: cetuximab (associated with radiotherapy);   Drug: cisplatin (associated to radiotherapy)
14 Recruiting Vitamin D - Celecoxib Therapy
Condition: Mouth Neoplasms
Interventions: Drug: 1,25-dihydroxyvitamin D3;   Drug: celecoxib;   Drug: 1,25-dihydroxyvitamin D3 + celecoxib
15 Not yet recruiting GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer
Conditions: Neoplasms, Oral;   Mouth Neoplasms
Intervention: Drug: GSK1120212
16 Recruiting Polarized Reflectance Spectroscopy for Oral Lesions
Condition: Oral Cancer
Intervention: Device: Polarized Reflectance Spectroscopy System
17 Unknown † The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma
Condition: Oral Cancer
Intervention:
18 Unknown † Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography
Condition: Oral Cancers
Intervention:
19 Recruiting Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
20 Unknown † Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
Condition: Oral Cancer
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services